The expression of<em>ABCC4/MRP4</em>and<em>ABCC5/MRP5</em>gene in the NK/T cell lymphoma and its relationship with clinical efficacy

李汝平; 韩丽娟; 张旭东; 张明智; 胡腾鹏; 秦贝贝; 文建国

doi:10.3969/j.issn.1007-3969.2014.01.002

您当前的位置：

首页 >

文章列表页 >

The expression ofABCC4/MRP4andABCC5/MRP5gene in the NK/T cell lymphoma and its relationship with clinical efficacy

更新时间：2025-12-31

- The expression ofABCC4/MRP4andABCC5/MRP5gene in the NK/T cell lymphoma and its relationship with clinical efficacy
- China Oncology Vol. 24, Issue 1, Pages: 8-14(2014)
- 作者机构：
  
  1. 郑州大学第一附属医院肿瘤科,河南,郑州,450052
  2. 河南省高等学校临床医学重点学科开放实验室,河南,郑州,450052
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2014.01.002
  CLC：
- Published Online：14 February 2014，
  
  Published：14 February 2014
- 稿件说明：
移动端阅览
李汝平,韩丽娟,张旭东,张明智,胡腾鹏,秦贝贝,文建国.

李汝平, 韩丽娟, 张旭东, et al. The expression ofABCC4/MRP4andABCC5/MRP5gene in the NK/T cell lymphoma and its relationship with clinical efficacy[J]. China Oncology, 2014, 24(1): 8-14.
李汝平,韩丽娟,张旭东,张明智,胡腾鹏,秦贝贝,文建国. DOI： 10.3969/j.issn.1007-3969.2014.01.002.

李汝平, 韩丽娟, 张旭东, et al. The expression ofABCC4/MRP4andABCC5/MRP5gene in the NK/T cell lymphoma and its relationship with clinical efficacy[J]. China Oncology, 2014, 24(1): 8-14. DOI： 10.3969/j.issn.1007-3969.2014.01.002.

摘要

背景与目的：NK/T细胞淋巴瘤(natural killer/T cell lymphoma)疗效差，多药耐药(multidrug resistance，MDR)的产生是引起肿瘤产生耐药和化疗疗效降低及失败的原因之一，本文通过研究多药耐药相关蛋白4(ABCC4 multidrug resistance associated protein，ABCC4/MRP)基因和多药耐药相关蛋白5(ABCC5 multidrug resistance associated protein，ABCC5/MRP)基因在NK/T细胞淋巴瘤SNK-6、YTS细胞株和组织中的表达情况，结合临床疗效了解其与预后的关系。方法：应用实时荧光定量PCR(real-time PCR)技术和免疫组织化学法(immunohistochemistry，IHC)检测ABCC4/MRP4、ABCC5/MRP5基因mRNA和蛋白表达水平。结果：与正常NK细胞相比，ABCC4/MRP4、ABCC5/MRP5基因在SNK-6、YTS细胞株中高表达(P0.05)；与鼻炎组织相比，ABCC4/MRP4、ABCC5/MRP5基因在NK/T细胞淋巴瘤患者组织中高表达(P0.05)；ABCC4/MRP4、ABCC5/MRP5基因表达量的高低和临床疗效呈负相关(P0.05)。结论：ABCC4/MRP4、ABCC5/MRP5基因及其表达蛋白影响NK/T细胞淋巴瘤的疗效。

Abstract

Background and purpose: Natural killer/T cell lymphoma in poor effects

the production of multidrug resistance is one of the reasons to reduce the chemotherapy effect or failure. This study aimed to discuss the multidrug resistance associated protein 4 (ABCC4/MRP4) gene and multidrug resistance associated protein 5 (ABCC5/MRP5) gene expression in NK/T cell lymphoma SNK-6

YTS cell lines and NK/T cell lymphoma tissues

and the relationship between the level of ABCC4/MRP4

ABCC5/MRP5 gene expression and the clinical efficacy. Methods: Real-time fluorescence quantitative PCR (Real time-PCR) and immunohistochemical method (IHC) were used to detect the ABCC4/MRP4

ABCC5/MRP5 gene and protein expression. Results: Compared with the normal NK cells

ABCC4/MRP4 and ABCC5/MRP5 gene in SNK-6

YTS cell lines were highly expressed (P0.05); Compared with rhinitis tissues

the expression of ABCC4/MRP4

ABCC5/MRP5 gene was higher in the NK/T cell lymphoma tissues (P0.05); The expression level of ABCC4/MRP4 and ABCC5/MRP5 gene was negative correlation with clinical efficacy (P0.05). Conclusion: The expression of ABCC4/MRP4 and ABCC5/MRP5 gene affects the of clinical efficacy of NK/T cell lymphoma.

关键词

Keywords

references

Views

2649

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI问答

⁰

The expression ofABCC4/MRP4andABCC5/MRP5gene in the NK/T cell lymphoma and its relationship with clinical efficacy

DOI：10.3969/j.issn.1007-3969.2014.01.002

摘要

Abstract

关键词

Keywords

references